drugset / Trial / NCT03035409

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

NCT03035409 ↗

Phase 2 Active not recruiting 129 enrolled M.D. Anderson Cancer Center National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelSupportive care

Summary

This phase II trial studies how well anamorelin hydrochloride, physical activity, and nutritional counseling work in decreasing cancer-related fatigue in patients with incurable solid tumors that have spread to other parts of the body or have come back. Anamorelin hydrochloride, physical activity, and nutritional counseling may help to decrease cancer-related fatigue in patients with solid tumors.

Timeline

Start
2017-02-08
Primary completion
2019-12-27
Completion
2028-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Anamorelin Small molecule 100 mg Oral